Karen Alderfer MD, Presenter: Nothing to Disclose

Ramon Ter-Oganesyan MD, Abstract Co-Author: Nothing to Disclose

Michael David Katz MD, Abstract Co-Author: Nothing to Disclose

Ilya Lekht MD, Abstract Co-Author: Nothing to Disclose

M. Victoria Marx MD, Abstract Co-Author: Nothing to Disclose

Sue Ellen Hanks MD, Abstract Co-Author: Nothing to Disclose

1. Overview of available liquid embolic agents and their conventional vascular uses. 2. Discussion of possible nonvascular uses. 3. Review of cases from our institution where liquid embolic agents have been utilized in nontraditional ways.

Liquid embolic agents      Review of currently available types of liquid embolic agents      and traditional vascular uses Discussion of nonvascular uses of liquid embolic agents      Hepatobiliary      Genitourinary      Gastrointestinal      Lymphatic Case discussion and imaging review      Detailed review of cases from our institution where liquid      embolic agents have been used in non-vascular organ      systems

NBCA glue (N- butyl cyanoacrylate) and Onyx® Liquid Embolic System (ethylene vinyl alcohol and DMSO (dimethyl sulfoxide)) have been used as vascular embolic agents in various parts of the body to arrest hemorrhage and shut down arteriovenous malformations. In our institution, the utility of these liquid embolic agents has been extended to nonvascular uses as well. In this presentation, we review several cases from our institution where liquid embolic agents have been utilized to achieve therapeutic success in biliary leaks, ureteral leaks, lymphatic leaks, and enterocutaneous fistulas.

Alderfer, K, Ter-Oganesyan, R, Katz, M, Lekht, I, Marx, M, Hanks, S, Nonvascular Uses of Liquid Embolic Agents: Therapy for Biliary Leaks, Ureteral Leaks, Lymphatic Leaks, and Enterocutaneous Fitsulas.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13012682.html